Abstract
T cell activation is regulated by two distinct signals, signals one and two. Concanavalin A (ConA) is an antigen-independent mitogen and functions as signal one inducer, leading T cells to polyclonal proliferation. CD28 is known to be one of major costimulatory receptors and to provide signal two in the ConA-induced T cell proliferation. Here, we have studied the implication of other costimulatory pathways in the ConA-mediated T cell proliferation by using soluble recombinant proteins consisting of an extracellular domain of costimulatory receptors and Fc portion of human IgG. We found that T cell proliferation induced by ConA, but not PMA plus ionomycin or anti-CD3 mAb, is significantly inhibited by herpes virus entry mediator (HVEM)-Ig, even in the presence of CD28 signaling. Moreover, the high concentration of HVEM-Ig molecules almost completely suppressed ConA-mediated T cell proliferation. These results suggest that HVEM might play more important roles than CD28 in ConA-mediated T cell proliferation.
Similar content being viewed by others
References
Abe R.; Vandenberghe P.; Craighead N.; Smoot D. S.; Lee K. P.; June C. H. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation. J. Immunol. 154: 985–997; 1995.
Ahmann G. B.; Sachs D. H.; Hodes R. J. Requirement for an Ia-bearing accessory cell in Con A-induced T cell proliferation. J. Immunol. 121: 1981–1989; 1978.
Appleman L. J.; Berezovskaya A.; Grass I.; Boussiotis V. A. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 164: 144–151; 2000.
Bretscher P. A. A two-step, two-signal model for the primary activation of precursor helper T cells. Proc. Natl. Acad. Sci. U. S. A. 96: 185–190; 1999.
Cai G.; Anumanthan A.; Brown J. A.; Greenfield E. A.; Zhu B.; Freeman G. J. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 9: 176–185; 2008.
Cai G.; Freeman G. J. The CD160, BTLA. LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol. Rev. 229: 244–258; 2009.
Chang C. P.; Yang M. C.; Liu H. S.; Lin Y. S.; Lei H. Y. Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model. Hepatology 45: 286–296; 2007.
Chatila T. A.; Schwartz D. H.; Miller R.; Geha R. S. Requirement for mitogen, T cell-accessory cell contact, and interleukin 1 in the induction of resting T-cell proliferation. Clin. Immunol. Immunopathol. 44: 235–247; 1987.
del Rio M. L.; Lucas C. L.; Buhler L.; Rayat G.; Rodriguez-Barbosa J. I. HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation. J. Leukoc. Biol. 87: 223–235; 2010.
Deppong C.; Degnan J. M.; Murphy T. L.; Murphy K. M.; Green J. M. B and T lymphocyte attenuator regulates T cell survival in the lung. J. Immunol. 181: 2973–2979; 2008.
Felipe I.; Bim S.; Somensi C. C. Increased clearance of Candida albicans from the peritoneal cavity of mice pretreated with concanavalin A or jacalin. Braz. J. Med. Biol. Res. 28: 477–483; 1995.
Harrop J. A.; McDonnell P. C.; Brigham-Burke M.; Lyn S. D.; Minton J.; Tan K. B.; Dede K.; Spampanato J.; Silverman C.; Hensley P.; DiPrinzio R.; Emery J. G.; Deen K.; Eichman C.; Chabot-Fletcher M.; Truneh A.; Young P. R. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J. Biol. Chem. 273: 27548–27556; 1998.
Kanaya K.; Tsuchida Y.; Inobe M.; Murakami M.; Hirose T.; Kon S.; Kawaguchi S.; Wada T.; Yamashita T.; Ishii S.; Uede T. Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model. Transplantation 75: 275–281; 2003.
Kaneko Y.; Harada M.; Kawano T.; Yamashita M.; Shibata Y.; Gejyo F.; Nakayama T.; Taniguchi M. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191: 105–114; 2000.
Kaposzta R.; Tree P.; Marodi L.; Gordon S. Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect. Immun. 66: 1708–1717; 1998.
Khoruts A.; Mondino A.; Pape K. A.; Reiner S. L.; Jenkins M. K. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187: 225–236; 1998.
Lei H. Y.; Chang C. P. Lectin of Concanavalin A as an anti-hepatoma therapeutic agent. J. Biomed. Sci. 16: 10; 2009.
Leo O.; Foo M.; Sachs D. H.; Samelson L. E.; Bluestone J. A. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. U. S. A. 84: 1374–1378; 1987.
Ma D. Y.; Clark E. A. The role of CD40 and CD154/CD40L in dendritic cells. Semin. Immunol. 21: 265–272; 2009.
Matsui Y.; Okamoto H.; Inobe M.; Jia N.; Shimizu T.; Akino M.; Sugawara T.; Tezuka K.; Nakayama Y.; Morimoto J.; Kimura C.; Kon S.; Miyazaki T.; Kitabatake A.; Uede T. Adenovirus-mediated gene transfer of ICOSIg fusion protein ameliorates ongoing experimental autoimmune myocarditis. Hum. Gene Ther. 14: 521–532; 2003.
Mauri D. N.; Ebner R.; Montgomery R. I.; Kochel K. D.; Cheung T. C.; Yu G. L.; Ruben S.; Murphy M.; Eisenberg R. J.; Cohen G. H.; Spear P. G.; Ware C. F. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8: 21–30; 1998.
McAdam A. J.; Chang T. T.; Lumelsky A. E.; Greenfield E. A.; Boussiotis V. A.; Duke-Cohan J. S.; Chernova T.; Malenkovich N.; Jabs C.; Kuchroo V. K.; Ling V.; Collins M.; Sharpe A. H.; Freeman G. J. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J. Immunol. 165: 5035–5040; 2000.
Miyagi T.; Takehara T.; Tatsumi T.; Suzuki T.; Jinushi M.; Kanazawa Y.; Hiramatsu N.; Kanto T.; Tsuji S.; Hori M.; Hayashi N. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver. Hepatology 40: 1190–1196; 2004.
Morel Y.; Truneh A.; Sweet R. W.; Olive D.; Costello R. T. The TNF superfamily members LIGHT and CD154 (CD40 Ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 167: 2479–2486; 2001.
Ono E.; Yoshino S.; Amagai K.; Taharaguchi S.; Kimura C.; Morimoto J.; Inobe M.; Uenishi T.; Uede T. Enhanced resistance to herpes simplex virus type 1 infection in transgenic mice expressing a soluble form of herpesvirus entry mediator. Virology 320: 267–275; 2004.
Perrin P. J.; Davis T. A.; Smoot D. S.; Abe R.; June C. H.; Lee K. P. Mitogenic stimulation of T cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation. Immunology 90: 534–542; 1997.
Rothstein D. M.; Sayegh M. H. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol. Rev. 196: 85–108; 2003.
Rudd C. E.; Taylor A.; Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol. Rev. 229: 12–26; 2009.
Salomon B.; Bluestone J. A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19: 225–252; 2001.
Sedy J. R.; Gavrieli M.; Potter K. G.; Hurchla M. A.; Lindsley R. C.; Hildner K.; Scheu S.; Pfeffer K.; Ware C. F.; Murphy T. L.; Murphy K. M. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6: 90–98; 2005.
Shahinian A.; Pfeffer K.; Lee K. P.; Kundig T. M.; Kishihara K.; Wakeham A.; Kawai K.; Ohashi P. S.; Thompson C. B.; Mak T. W. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261: 609–612; 1993.
Simpson T. R.; Quezada S. A.; Allison J. P. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr. Opin. Immunol. 22: 326–332; 2010.
Sinclair N. R. Why so many coinhibitory receptors? Scand. J. Immunol. 50: 10–13; 1999.
Tamada K.; Shimozaki K.; Chapoval A. I.; Zhai Y.; Su J.; Chen S. F.; Hsieh S. L.; Nagata S.; Ni J.; Chen L. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164: 4105–4110; 2000.
Tiegs G.; Hentschel J.; Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90: 196–203; 1992.
Toyabe S.; Seki S.; Iiai T.; Takeda K.; Shirai K.; Watanabe H.; Hiraide H.; Uchiyama M.; Abo T. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 159: 1537–1542; 1997.
Wallach D.; Varfolomeev E. E.; Malinin N. L.; Goltsev Y. V.; Kovalenko A. V.; Boldin M. P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17: 331–367; 1999.
Walunas T. L.; Lenschow D. J.; Bakker C. Y.; Linsley P. S.; Freeman G. J.; Green J. M.; Thompson C. B.; Bluestone J. A. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405–413; 1994.
Weiss A.; Shields R.; Newton M.; Manger B.; Imboden J. Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene. J. Immunol. 138: 2169–2176; 1987.
Yang M. C.; Chang C. P.; Lei H. Y. Endothelial cells are damaged by autophagic induction before hepatocytes in Con A-induced acute hepatitis. Int. Immunol. 22: 661–670; 2010.
Yokoyama Y. M.; Koning F.; Kehn P. J.; Pereira G. M. B.; Stingl G.; Coligan J. E.; Shevach E. M. Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J. Immunol. 141: 369–376; 1988.
Acknowledgements
We thank Chiemi Kimura and Hisako Yata for the preparation of Ig-fusion molecules. This study was partly supported by the Takeda foundation.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: T. Okamoto
Rights and permissions
About this article
Cite this article
Ando, Y., Yasuoka, C., Mishima, T. et al. Concanavalin A-mediated T cell proliferation is regulated by herpes virus entry mediator costimulatory molecule. In Vitro Cell.Dev.Biol.-Animal 50, 313–320 (2014). https://doi.org/10.1007/s11626-013-9705-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-013-9705-2